Capital Wealth Alliance’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Capital Wealth Alliance's ABBV Position: Q1 2025 in Review
Capital Wealth Alliance sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 22,982 shares — an estimated $4.08M sold.
Capital Wealth Alliance first reported a position in ABBV in Q4 2019 and held it in 21 quarters. The position peaked at $4.54M in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.
- Capital Wealth Alliance reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
- Capital Wealth Alliance sold 22,982 AbbVie shares in Q1 2025, an estimated $4.08M.
- Capital Wealth Alliance first reported a position in AbbVie in Q4 2019 and held it in 21 quarters.
- Capital Wealth Alliance's AbbVie position peaked at $4.54M in Q3 2024.
- 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.
Based on Capital Wealth Alliance's 13F filing for Q1 2025, filed 14 May 2025.